Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Mindset Pharma

Most, But Not All, Psychedelics Companies Have Sufficient Liquidity

The Chart represents the liquidity positions of the 21 Psychedelic sector companies in the Viridian Value Tracker database.

Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014

Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014

Mindset Pharma Inc.

Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders

Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders

Mindset Pharma Inc.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 4.22% at $0.46

Mindset Pharma, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 8.24% at $0.18

Is Wall Street The Next Stop For Psychedelics? Investing In The Psychedelic Medicine Sector

This article was originally published on Psychedelic Spotlight and appears here with permission. Elemental Advisors Inc. CEO Tim Collins paints a picture of the past, present, and future of the psychedelics market in this guest blog for Psychedelic Spotlight. The use of psychedelic drugs to treat mental health conditions is…

Five Companies Developing Second Generation Psychedelics For Mental Health

Along with the psychedelic renaissance came a new type of drug: second generation psychedelics. Developed from classic psychedelics molecules, these upgraded compounds could offer improved therapeutic profiles with reduced side effects. For some companies in the psychedelics space, second generation psychedelics could be the key to success in an increasingly…

inkl

Read news from The Economist, FT, and more,
with one subscription

Mindset Pharma, Compass Pathways Among Top Psychedelic Movers Of Today

Mindset Pharma, Compass Pathways Among Top Psychedelic Movers Of Today

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 6.03% at $1.23

Field Trip Health, Mindset Pharma Among Top Psychedelic Movers Of Today

Field Trip Health, Mindset Pharma Among Top Psychedelic Movers Of Today

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 12.06% at $1.58

Psychedelic Stock Gainers And Losers From March 16, 2022

Psychedelic Stock Gainers And Losers From March 16, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 9.63% at $0.44

Psychedelic Stock Gainers And Losers From March 2, 2022

Psychedelic Stock Gainers And Losers From March 2, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 7.19% at $0.47

Psychedelic Stock Gainers And Losers From February 22, 2022

Psychedelic Stock Gainers And Losers From February 22, 2022

GAINERS: LOSERS: Mindset Pharma (OTC:MSSTF) shares closed down 12.73% at $0.48

Psychedelic Stock Gainers And Losers From February 17, 2022

Psychedelic Stock Gainers And Losers From February 17, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 9.89% at $0.55

Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today

Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today

GAINERS: Awakn Life Sciences (OTC:AWKNF) shares closed up 3.51% at $1.62

Get all your
news in one place.

100’s of premium titles.
One news app.

Mindset Pharma, Allied Among Top Psychedelic Movers Of Today

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 15.70% at $0.69

Psychedelic Stock Gainers And Losers From January 28, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 17.86% at $0.57

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 6.29% at $0.49

Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 25.48% at $1.17

Get all your
news in one place.

100’s of premium titles.
One news app.

Mindset Pharma Teams Up With The McQuade Center To Develop 2 Families Of Novel Psychedelic Compounds

This article was originally published on Psychedelic Spotlight and appears here with permission. It’s yet another sign that the pharmaceutical industry at large is taking the potential of psychedelics very seriously.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Compass Pathways

Field Trip Health

Psychedelic Spotlight

Viridian Cannabis Deal Tracker

Nature Medicine

JAMA Psychiatry

Enveric Biosciences

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

243,741 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play